HealthTeva to discontinue mid-stage neurodegenerative disorder study

Teva Pharmaceuticals said on Monday it would stop its mid-stage study of a neurodegenerative disorder because the study was unlikely to meet its main goal if continued.

Teva Pharmaceuticalsneurodegenerative disordersclinical study

RReuters★★☆☆☆2026-11-02 15:45Original